sivextro
merck sharp & dohme b.v. - tedizolid phosphat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
monurol 2 g granulat til oral opløsning, enkeltdosisbeholder
zambon s.p.a. - fosfomycintrometamol - granulat til oral opløsning, enkeltdosisbeholder - 2 g
fosfomycin "1a farma" 3 g pulver til oral opløsning
1a farma a/s - fosfomycintrometamol - pulver til oral opløsning - 3 g
methenamine hippurate "eql pharma" 1 g tabletter
eql pharma ab - methenaminhippurat - tabletter - 1 g
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler til systemisk brug, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
linezolid "accord" 600 mg filmovertrukne tabletter
accord healthcare b.v. - linezolid - filmovertrukne tabletter - 600 mg
linezolid "accord" 2 mg/ml infusionsvæske, opløsning
accord healthcare b.v. - linezolid - infusionsvæske, opløsning - 2 mg/ml
linezolid "actavis" 2 mg/ml infusionsvæske, opløsning
actavis group ptc ehf. - linezolid - infusionsvæske, opløsning - 2 mg/ml
linezolid "aristo" 2 mg/ml infusionsvæske, opløsning
aristo pharma gmbh - linezolid - infusionsvæske, opløsning - 2 mg/ml
linezolid "fresenius kabi" 2 mg/ml infusionsvæske, opløsning
fresenius kabi ab - linezolid - infusionsvæske, opløsning - 2 mg/ml